Session

Oligometastatic prostate cancer

ESU Course 45

  • Location:
    Room 15, Capital suite (level 3)
  • Chair:
     R.J. Karnes, Rochester (US)
  • Aims and objectives of this session

    – Provide an introduction to working definition(s), background, and biology of oligometastatic prostate cancer
    – Update the current molecular imaging to provide such a diagnosis
    – Review the potential roles of surgery and/or radiation as metastasis directed therapy
    – Understand opportunities and challenges in individualizing care of the oligometastatic prostate cancer patient

Introductions; Oligometastatic prostate cancer as a diagnosis
 R.J. Karnes, Rochester (US)
Surgery for recurrent nodal metastasis with updates on molecular/PET imaging
 A. Briganti, Milan (IT)
Radiation in oligometastatic prostate cancer (primary and recurrent) and clinical trial updates
 P. Ost, Ghent (BE)
Surgery of primary oligometastatic prostate cancer (N1/M1)
 R.J. Karnes, Rochester (US)
Further cases (case illustrations throughout)
 A. Briganti, Milan (IT)
 
 R.J. Karnes, Rochester (US)
 
 P. Ost, Ghent (BE)
Questions audience